渉外（ロビイング）／メディカル（医薬品・CRO・医療機器）の求人・転職情報

Role Summary

The Senior Manager, Policy plays a pivotal role in advancing Pfizer’s policy strategy and initiatives in Japan, aligning with the company’s purpose of delivering breakthroughs that change patients' lives and its business priorities in Japan. This strategic, externally oriented position requires strong commercial acumen and broad stakeholder engagement, serving as a key liaison between Pfizer and external stakeholders, including policymakers, industry associations, and other thought leaders, to drive impactful policy programs.

As part of the International Policy and Communications (IPC), the role collaborates closely with the other IPC functions, Communications and Community Engagement, as well as with other internal partners and external stakeholders, both in Japan and globally, to enhance policy impact and operational efficiency.


Role Responsibilities

Develop and implement external stakeholder engagement strategies, fostering trusted relationships with policymakers (including Diet members, central and local government officials) as well as key influencers such as academics and think tanks.
Provide strategic policy support to advance business objectives, driving internal and external initiatives aligned with relevant therapeutic areas and policy domains.
Monitor and analyze political, legislative, and healthcare policy developments, providing timely strategic advice to senior leaders and proactively addressing risks and opportunities affecting Pfizer’s business, reputation, and market access in Japan.
Develop and implement strategic projects, ensuring clear and effective communication of the company’s priorities and policy positions.
Collaborate across all business units to design and articulate impactful policy frameworks, delivering strategic initiatives that address key policy priorities in Japan.
Influence policy-making by raising public awareness and partnering with third-party organizations, in coordination with the Communications and Community Engagement teams.
Develop clear, evidence-based policy positions, briefing materials, and other external-facing content to support policy development and advocacy.
Represent the company’s interests and perspectives in industry association policy activities.

・医療・ヘルスケア領域における広報・渉外戦略の立案および実行
・患者団体、医療関係者、メディアとの関係構築・コミュニケーション推進
・疾患啓発活動やアドボカシープログラムの企画・運営
・グローバルおよび国内関連部門と連携した企業・ブランド認知向上施策の推進
・社会的意義の高い革新的な医療ソリューションの普及と認知向上

日本国内における血液疾患領域の製品ポートフォリオの市場アクセス戦略を主導する
グローバル市場アクセス部門と日本法人との間の連絡窓口を務める
HTA（医療技術評価）資料を含む、国民健康保険（NHI）の価格設定および償還申請を推進する
製品戦略に沿った価格交渉およびHTA交渉を実施する
償還政策の変更を監視し、ビジネスへの影響を評価する
日本特有の知見を提供し、価値戦略やエビデンス計画の策定に貢献する
グローバルなアクセスフォーラムや発売準備レビューにおいて、日本を代表して参加する
多様なステークホルダーが存在する、協働的で変化し続ける環境において、その能力を最大限に発揮できる方

【職務概要】
職務概要渉外部のアソシエイトディレクターは、ビジネスを取り巻く医療制度・規制環境を分析し、社外ステークホルダーやリソースとの関係構築、維持、活用により、政策分野におけるのビジネス優先事項を推進する。アソシエイトディレクターは、MAHPのディレクターにレポートする。またアソシエイトディレクターは、MAHPのメンバーや他部署、グローバルチームとも緊密に連携し業務を遂行する。

【業務内容】
• 医療制度・規制による影響を分析・評価し、関連部署やシニアマネジメントへタイムリーに情報共有する• ビジネスにおける政策課題を特定し、それを克服するための戦略プランを策定、実行する• 外部の政策ステークホルダー（KOL、患者アドボケート、アカデミア、医療政策関係者等）と関係を構築、維持する• 業界活動への参画、貢献を通じて、希少疾患領域におけるアレクシオンの存在感を拡大する• 社員へ医療制度・規制の教育機会を提供する• 医療制度・規制に関する社内外からの問い合わせに対し回答、助言を行う• マーケティング、メディカル、広報、ペイシェントアドボカシー、R&D、グローバルなど社内の主要な部署と円滑に連携をする

Basic purpose of the job

The purpose of this position is to develop and execute plans that maximize asset value during the late stages of the product life cycle.

To achieve these objectives, the person assigned to this position develops plans based on the most appropriate measure, or combination of measures, selected from a broad range of options—including product divestment, development of new distribution models, optimization of pricing strategies, and acceleration of product discontinuation processes—and leads the activities required for their implementation.


Accountabilities

Develop strategies to maximize value of assets during the late-stage of product life cycle amid the challenges for profitability, sustainability, or continuation of commercialization.

Related performance indicators

- Strategies develop for designated products within agreed timelines
- Strategies updated in response to material changes in the business circumstances


Recommend the most appropriate measure or combination of measures, supported by robust business assessments.

Related performance indicators

- Strategic options assessed using clear and consistent decision criteria
- Recommendations endorsed by the relevant decision-making body



Develop and implement plans to preserve asset value through pricing and distribution measures.

Related performance indicators

- Pricing and distribution initiatives implemented in line with approved plans and timelines


Lead product divestment activities from opportunity assessment and partner engagement in collaboration with relevant internal functions.

Related performance indicators

- Divestment opportunities assessed and progressed in accordance with the approved strategy
- Transfer completed in accordance with the agreed transition plan



Lead product discontinuation assessments and execute approved discontinuation plans.

Related performance indicators

- Discontinuation assessments and recommendations completed
- Progress against the approved discontinuation plan milestones


Regulatory and / or Organisational Requirements



Job Complexity

In the late stages of the pharmaceutical product life cycle, changes in the market environment cause product profitability to decline more rapidly and significantly.

In this environment, life cycle management plan including business development approaches, measures to maintain profitability of patent expired products and product discontinuation is critical to secure financial resources for new assets development and to renew the product portfolio.

The life cycle management leads will be required capabilities for developing business plans and for negotiating with multiple internal/external stakeholders.

This management plan is needed to be tailored to specific situation of each product.


Interfaces

Internal:
Senior leaders, TA (Global/local), Finance, Legal, C-SCM(Global/Local)

External:
Pharmaceutical companies


Job Expertise

Business Development, Finance, Pharmaceutical Regulatory Affairs


Job Impact

This position is focused on enhancing the commercial value of products in the late life cycle management stage, whose business performance is currently experiencing an accelerated decline.

【職務内容 Job Description】
Establish optimal Pricing & Market Access strategy for key products from an earlier development stage (PII～JNDA). Achieve target price for reonsible products through strategic negotiations with MHLW.

・Lead strategic price negotiation with MHLW on responsible products and manage preparation for the negotiation. 
・Assess price potential of assigned products under close collaboration with Market Access group.
・Contribute to business planning with insightful analysis on healthcare & pricing environment change through close monitoring of discussion at Government councils and pricing tendency. 
・Collaborate with other departments to gain support for optimal pricing based on pricing strategy for responsible products.
・Collaborate with Global Pricing & Market Access in order to align our pricing strategy on responsible products with global strategy, and gain support from global team as needed basis.
・Build strong relationship with MHLW officials and industry colleagues through trade association activities, and leverage them for optimal pricing outcome. 
・Educate stakeholders in the global HQs about Japanese pricing system and health insurance-related systems.

We are seeking a Market Access Associate Manager, Rare Disease Portfolio, Japan, to join our Market Access team, supporting our Japan affiliate in a hybrid work model. In this role, you will drive launch, pricing, and reimbursement strategies for the rare disease portfolio while collaborating with commercial, marketing, HEOR (health economics and outcomes research), medical affairs, clinical, and global market access strategy teams. This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.

■ 職務内容 / Job Description
Conduct CEA (cost effectiveness analysis) effectively and prepare strategic HTA (health technology assessment) materials in order to minimize price cuts for responsible products under the Official CEE (Cost Effectiveness Evaluation). Typical accountabilities are as follows:
• Accomplish CEA according to the guidelines and generate plausible results in collaboration with internal and external people concerned (make a plan, collect necessary information, generate necessary data, conduct multiple analyses, and develop materials)
• Prepare required materials and negotiate with C2H/MHLW in the official CEE process.
• Make a suggestion to Pricing & Market access strategy in terms of HTA
• Collect updated information about technical knowledge, HTA system, and leverage them for our activities

1. 事業運営の型化とスケーラビリティの担保
各部門（営業、CS、マーケ、BizOpsなど）の業務プロセスを標準化
ヒト依存のオペレーションを「仕組み化」して再現性ある成長モデルへ
新規拠点／新市場への展開時も、同様の成果を出せる運営体制を設計

2. 戦略の実行計画策定と推進
事業戦略の立案から、具体的な目標設定および実行計画への落とし込み
現場と経営層との認識齟齬を解消する「推進役」として、意思決定と実行の両側面を担う

3. ミドルマネジメント層の育成・強化
プレイングマネージャー主体の体制から、役割が明確に分担された中間層組織への移行を主導
採用・評価・育成を通じて、マネジメントラインの強化と組織レイヤーの構築を推進

4. 事業KPIの設計とモニタリング
成長フェーズに合わせたKPI体系の見直し（LTV、CAC、NPSなど）
各部門の進捗と成果を数値で見える化し、データドリブンで事業を管理

5. 組織統制と事業成長の加速化の両立
組織規模の拡大、事業拠点の増加、業務の複雑化に対応しながらも、スタートアップ企業としての事業推進スピードを維持
管理部門および法務・労務体制の強化を含む統制の取れた組織拡大を、関係部署と連携の上で推進

職種概要（The Role & Department）
Senior Manager, Market Access, Pricing & Government Affairsは、Director, Market Access, Pricing & Government Affairsに報告します。
主な役割は、厚生労働省（MHLW）との薬価交渉のリードおよび準備管理、価格戦略の視点からの医薬品開発および商業化支援、市場およびパイプライン製品の価格予測、政府施策に対応した戦略の策定・実行、業界団体活動への参画を含みます。

主な職務責任（Key Accountabilities）
新規製品および既存製品の薬価交渉を厚労省とリードし、交渉準備を管理する。
臨床開発計画や商業戦略の議論に参加し、価格戦略の観点から意見を提供する。
今後上市予定および既に上市している製品の将来価格予測を行い、長期的に有利な価格維持戦略を策定する。
政府の政策動向や重要な政策変更の情報を収集し、適切な対策を立案。市場アクセスおよび価格に影響する政策情報を社内に共有し、戦略的対応が必要な事項を関係者に提供する。業界団体活動に参加し、ネットワーキングを通じてインサイトを収集するとともに、業界の立場形成に貢献する。

医療制度・政策に関する情報収集、関係先との関係構築
チームマネジメント